Peptide 101: What a Peptide Actually Is (and How We Got Here)

🇪🇸 Leer este artículo en español

By Charles / July 2026

By Charles Fowler, Founder of Portal to Wellness · Last reviewed: July 2026 · ~8 min read

A quick note on why I wrote this: I’m not a doctor — I’m a founder who spends my days deep in the wellness and research-compound space, reading the literature and vetting what we carry. I built this guide because I keep hearing a version of the same question: “Wait, is that a peptide too?” It usually comes up when someone who knows peptides from one corner of the world — skincare, diabetes care, weight management, the research space — realizes the word shows up everywhere else too. This is the guide I wish someone had handed me on day one. Everything below is educational only and reflects published, publicly available history and research, not medical advice. Please talk to a qualified healthcare professional before changing your health routine.

What you’ll learn in this article

• What a peptide actually is, chemically, and how it’s different from a protein
• How insulin became the first peptide medicine ever made — and later the first genetically engineered drug
• How that same chemistry quietly ended up in your skincare routine
• The real story behind GLP-1 drugs like Ozempic and Mounjaro (it starts with a venomous lizard)
• Where today’s research-use peptides — BPC-157, TB-500, and others — fit into the bigger picture
• A simple way to sort any peptide you hear about into one of three categories

Why “peptide” means more than you think

If you work in skincare, “peptide” probably means a wrinkle cream ingredient. If you or someone you love manages diabetes, “peptide” might mean insulin. If you’ve followed the last few years of weight-management news, “peptide” is probably shorthand for Ozempic or Mounjaro. If you spend time in research or performance communities, “peptide” might mean something like BPC-157 or a research-use compound.

Here’s the thing: all of those people are talking about the same category of molecule. Peptides aren’t one product or one industry — they’re a whole class of biological building blocks, and different fields have been independently discovering uses for them for over a century. Once you see the throughline, none of it seems disconnected anymore.

What a peptide actually is

A peptide is a short chain of amino acids linked together by what chemists call a peptide bond. Amino acids are the basic building blocks of biology — think of them like letters. String a few together and you get a word (a peptide); string together a long paragraph of them and you get a protein.

The distinction between a “peptide” and a “protein” is really just one of size and structure, not a difference in fundamental chemistry. The conventional cutoff is around 50 amino acids: shorter chains are generally called peptides, longer ones are called proteins. Peptides also tend to be simpler in shape — proteins fold into complex 3D structures, while peptides are usually more like a short, flexible chain. Insulin, in fact, sits right at that blurry line: it’s technically a small protein made of two peptide chains linked together, and it’s commonly described as a “peptide hormone” in both scientific and popular writing.

Because peptides are small, precisely structured, and biologically active in tiny amounts, they’re extraordinarily useful signaling molecules. Your body uses thousands of them naturally — as hormones, neurotransmitter helpers, and messengers that tell cells what to do. That natural role is exactly why scientists have spent a century figuring out how to identify, copy, and eventually manufacture specific peptides for medicine, skincare, and now research.

The 100-year history, in five chapters

Chapter 1: Insulin — the first peptide medicine (1921–1923)

The peptide story most people don’t realize is a peptide story starts with insulin. Before 1921, a type 1 diabetes diagnosis was a death sentence, usually within a year or two. In the spring and summer of 1921, Frederick Banting and Charles Best, working in a University of Toronto lab with biochemist James Collip refining their extract, isolated the hormone from pancreatic tissue. Clinical results in January 1922 showed it lowered blood sugar in a patient dying of the disease, and the discovery was formally published in February 1922. By May 1922, the University of Toronto reached a manufacturing agreement with Eli Lilly and Company, and by the fall of 1923, insulin was in general distribution — the first time in history a peptide had gone from laboratory discovery to a manufactured medicine saving lives at scale. Banting and Macleod received the Nobel Prize in 1923, the same year insulin reached patients.

For six decades after that, insulin was extracted from the pancreases of cows and pigs. That changed on October 28, 1982, when the FDA approved Humulin — human insulin manufactured by inserting the human insulin gene into bacteria and letting them produce it. It was the first genetically engineered drug ever approved, and it quietly established the manufacturing playbook — using living cells or chemical synthesis to build a specific peptide sequence on purpose — that the entire modern peptide industry, from pharmaceuticals to research compounds, still relies on today.

Chapter 2: Peptides move into skincare (1970s onward)

While insulin was becoming a mainstream medicine, a separate and completely unrelated discovery was happening in wound-care research. In 1973, researcher Loren Pickart noticed that blood plasma from younger donors healed tissue more effectively than plasma from older donors, and traced the difference to a small copper-binding peptide called GHK-Cu (glycyl-L-histidyl-L-lysine, bound to copper). It was originally studied for wound healing, not beauty — but the regenerative signaling researchers observed is exactly what caught the skincare industry’s attention over the following decades. Copper peptides, along with later synthetic signal peptides developed specifically for cosmetic formulations, became a mainstay of the “anti-aging” skincare aisle, which is where most consumers first ever encounter the word “peptide” on a product label.

Chapter 3: GLP-1s — from lizard venom to the biggest drug story in a generation (1990s–today)

In the 1960s and 70s, researchers noticed something curious: eating glucose triggers a much bigger insulin response than receiving glucose intravenously. Something in the gut was amplifying insulin release. It took until the 1980s, using new peptide-sequencing tools, to identify one of the culprits: a peptide called GLP-1 (glucagon-like peptide-1), clipped from a larger precursor protein.

The molecule that turned this into a medicine came from an unexpected place. In the early 1990s, endocrinologist John Eng discovered a peptide called exendin-4 in the venom of the Gila monster, a venomous desert lizard — and found it behaved remarkably like human GLP-1, but lasted much longer in the body. That discovery became exenatide, brand name Byetta, approved by the FDA in 2005 as the first GLP-1 receptor agonist medicine. From there, the chemistry kept improving: liraglutide (Victoza) in 2010 extended the effect to once-daily dosing, semaglutide arrived as Ozempic (2017) and later Wegovy (2021), and tirzepatide — which acts on two gut-hormone pathways at once — arrived as Mounjaro (2022) and Zepbound (2023). Every one of those medicines is, at its core, a peptide engineered to mimic or extend a signal your gut already sends.

Chapter 4: The research-compound era (2010s–today)

Over roughly the last fifteen years, alongside (and often inspired by) the pharmaceutical peptide boom, a much broader wave of peptide research has taken off — compounds like BPC-157 and TB-500 are probably the best-known names. These are studied in laboratory and preclinical settings for topics like tissue repair and recovery science. This is also the category where a lot of confusion creeps in, so it’s worth being precise: peptides in this category are not FDA-approved drugs, and they’re generally sold strictly for laboratory research use, not for human consumption. That’s the world Portal to Wellness operates in — we’re a research-use supplier, not a pharmacy, and nothing here should be read as a claim about what any compound does in the human body.

Chapter 5: Where that leaves us today

Put the five chapters together and you get the real picture: “peptide” was never one industry’s word. It’s a chemistry term that medicine, skincare, and research science all independently found their way to, because short amino acid chains happen to be one of biology’s most useful design patterns. Today the word shows up on an insulin pen, a wrinkle cream label, a GLP-1 prescription, and a research-compound vial — and all four are legitimately using the term correctly.

Three buckets worth knowing

If it’s useful to sort what you’re hearing about, most peptides people talk about fall into one of three buckets:

FDA-approved peptide medicines — insulin, GLP-1 drugs like semaglutide and tirzepatide, and others. These go through clinical trials, carry prescribing information, and are dispensed by pharmacies under medical supervision.

Cosmetic peptides — ingredients like copper peptides and synthetic signal peptides formulated into skincare products, regulated as cosmetics rather than drugs.

Research-use peptides — compounds studied in laboratory settings, sold strictly for research purposes to qualified buyers, not intended for human use, and not FDA-approved for any therapeutic purpose. This is the category most relevant to what we carry.

Knowing which bucket you’re talking about clears up almost every “wait, is that a peptide too?” conversation.

The bottom line

Peptides are simply short chains of amino acids — one of biology’s most fundamental design tools. What makes the topic feel confusing isn’t the chemistry, it’s that four very different industries (pharmaceuticals, skincare, clinical medicine, and research science) have each been building on that same chemistry for decades, mostly without talking to each other. Once you know the history, the word stops feeling scattered and starts making sense as one continuous story.

Frequently asked questions

Is insulin a peptide?
Yes. Insulin is a small protein made of two linked peptide chains and is routinely described as a peptide hormone in scientific literature.

Are GLP-1 drugs like Ozempic and Mounjaro peptides?
Yes. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are peptide-based medicines engineered to act on gut-hormone signaling pathways.

Are skincare peptides the same thing as research peptides?
Chemically, they’re the same category of molecule — short amino acid chains — but they’re used, regulated, and sold in completely different ways. Cosmetic peptides are formulated into topical products and regulated as cosmetics. Research peptides are sold strictly for laboratory research use, not for human consumption, and are not FDA-approved for any therapeutic purpose.

Are research peptides FDA-approved?
No. Research-use peptides are not approved by the FDA for any medical use. They’re sold to qualified buyers strictly for research purposes, not as drugs or supplements for human consumption.

Related reading

• NAD+ Explained: Levels and Science
• FDA Is Reviewing Popular Peptides: What Researchers Should Know

About the author

Charles Fowler is the founder and researcher behind Portal to Wellness. After a career in management consulting, he has spent several years exploring health optimization — the last three focused on the research-compound space — sourcing products, vetting suppliers, and reading the primary literature daily. He isn’t a physician or a scientist, and he’ll tell you so. His goal is to translate what the research actually says into plain English so customers can make informed decisions. When the evidence is uncertain, he says so.

How we research our content

Our Learn Center articles are written from peer-reviewed scientific literature and reputable references, and we date every article so you know how current it is. We don’t make therapeutic, dosing, or “cure” claims, and we flag clearly where the science is still unsettled. If we get something wrong or new evidence emerges, we update the article. Have a correction or a question? Reach out — we read every message.

References

• Peptides vs. Proteins: What Is the Difference? Britannica. britannica.com
• Biochemistry, Peptide. StatPearls, NCBI Bookshelf, National Institutes of Health. ncbi.nlm.nih.gov
• 100 Years of Insulin. U.S. Food and Drug Administration. fda.gov
• Banting and Best Discover Insulin. UMass Chan Medical School. umassmed.edu
• Exendin-4: From Lizard to Laboratory… and Beyond. National Institute on Aging, NIH. nia.nih.gov
• A Brief History of GLP-1 Agonists. History Cooperative. historycooperative.org
• Copper Peptides (GHK-Cu). DermApproved. dermapproved.com
• Is the Peptide Craze Backed by Science? Nature. nature.com
• The Science Behind the Peptide Craze. Scientific American. scientificamerican.com

This article is for informational and educational purposes only. It is not medical advice and does not describe the diagnosis, treatment, cure, or prevention of any disease. Portal to Wellness products are sold for research purposes only. Always consult a qualified healthcare professional before making changes to your health routine.